A Review of Classical Swine Fever
virus and Routes of introduction
into the United States and the
Potential for virus establishment by Brown, Vienna R. & Bevins, Sarah N.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
USDA National Wildlife Research Center - Staff
Publications
U.S. Department of Agriculture: Animal and Plant
Health Inspection Service
2018
A Review of Classical Swine Fever virus and Routes
of introduction into the United States and the
Potential for virus establishment
Vienna R. Brown
Oak Ridge Institute for Science and Education, vienna.r.brown@aphis.usda.gov
Sarah N. Bevins
US Department of Agriculture, Sarah.N.Bevins@aphis.usda.gov
Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc
Part of the Life Sciences Commons
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health Inspection Service at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA National Wildlife Research Center - Staff Publications
by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
Brown, Vienna R. and Bevins, Sarah N., "A Review of Classical Swine Fever virus and Routes of introduction into the United States
and the Potential for virus establishment" (2018). USDA National Wildlife Research Center - Staff Publications. 2081.
https://digitalcommons.unl.edu/icwdm_usdanwrc/2081
March 2018 | Volume 5 | Article 311
Review
published: 05 March 2018
doi: 10.3389/fvets.2018.00031
Frontiers in Veterinary Science | www.frontiersin.org
Edited by: 
Javier Bezos, 
Complutense University 
of Madrid, Spain
Reviewed by: 
Luis Gustavo Corbellini, 
Federal University of Rio 
Grande do Sul (UFRGS), Brazil  
Fedor Korennoy, 
Federal Center for Animal Health 
(FGBI ARRIAH), Russia
*Correspondence:
Vienna R. Brown  
vienna.r.brown@aphis.usda.gov
†Oak Ridge Institute for Science and 
Education (ORISE) supported by the 
U.S. Department of Homeland 
Security (DHS) Science and 
Technology Directorate (S&T) 
Homeland Security Advanced 
Research Projects Agency (HSARPA), 
Chemical and Biological Defense 
Division (CBD) under Agreement # 
HSHQPM-13-X-00174.
Specialty section: 
This article was submitted 
to Veterinary Epidemiology 
and Economics, 
a section of the journal 
Frontiers in Veterinary Science
Received: 15 September 2017
Accepted: 15 February 2018
Published: 05 March 2018
Citation: 
Brown VR and Bevins SN (2018) 
A Review of Classical Swine 
Fever Virus and Routes of 
Introduction into the United States 
and the Potential for Virus 
Establishment. 
Front. Vet. Sci. 5:31. 
doi: 10.3389/fvets.2018.00031
A Review of Classical Swine Fever 
virus and Routes of introduction  
into the United States and the 
Potential for virus establishment
Vienna R. Brown1*† and Sarah N. Bevins2
1 Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN, United States, 2 United States Department of 
Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, Fort Collins, 
CO, United States
Classical swine fever (CSF) is caused by CSF virus (CSFV) which can be the source 
of substantial morbidity and mortality events in affected swine. The disease can take 
one of several forms (acute, chronic, or prenatal) and depending on the virulence of the 
inoculating strain may result in a lethal infection irrespective of the form acquired. Because 
of the disease-free status of the United States and the high cost of a viral incursion, a 
summary of US vulnerabilities for viral introduction and persistence is provided. The legal 
importation of live animals as well as animal products, byproducts, and animal feed serve 
as a potential route of viral introduction. Current import regulations are described as are 
mitigation strategies that are commonly utilized to prevent pathogens, including CSFV, 
from entering the US. The illegal movement of suids and their products as well as an event 
of bioterrorism are both feasible routes of viral introduction but are difficult to restrict or 
regulate. Ultimately, recommendations are made for data that would be useful in the event 
of a viral incursion. Population and density mapping for feral swine across the United 
States would be valuable in the event of a viral introduction or spillover; density data could 
further contribute to understanding the risk of infection in domestic swine. Additionally, 
ecological and behavioral studies, including those that evaluate the effects of anthro-
pogenic food sources that support feral swine densities far above the carrying capacity 
would provide invaluable insight to our understanding of how human interventions affect 
feral swine populations. Further analyses to determine the sampling strategies necessary 
to detect low levels of antibody prevalence in feral swine would also be valuable.
Keywords: classical swine fever, viral introduction, domestic swine, feral swine, emergency preparedness
KeY POiNTS
•	 Classical	 swine	 fever	 (CSF)	 is	 currently	 a	 foreign	 animal	disease	 in	 the	United	 States	 and	 the	
economic	consequences	associated	with	an	introduction	could	be	severe.
•	 The	virus	is	endemic	in	many	parts	of	the	world,	including	Central	America,	Africa,	Asia,	and	
parts	of	South	America.
•	 Classical	swine	fever	virus	is	most	likely	to	be	introduced	to	the	US	via	the	legal	or	illegal	impor-
tation	of	animals	or	their	products.
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•	 Feral	swine	involvement	would	significantly	challenge	disease	
control	and	eradication	methods.
•	 Effective	live	attenuated	vaccines	are	available	for	use;	however,	
antibodies	 generated	 against	 the	 current	 vaccines	 cannot	 be	
differentiated	from	those	generated	during	a	natural	infection	
which	complicates	control	and	eradication	methods.
•	 Future	 research	 should	 involve	 (1)	density	mapping	of	 feral	
swine	populations	in	the	US	as	well	as	long-term	studies	on	
a	fine	spatial	scale	to	evaluate	contact	dynamics,	and	move-
ment	ecology	based	on	habitat	and	seasonality,	of	feral	swine	
as	 these	 components	 are	 important	 for	 contact	 and	 subse-
quently,	disease	transmission,	(2)	studies	to	evaluate	the	effect	
of	 anthropogenic	 food	 sources	 on	 home	 range	 and	 density	
of	 feral	 swine,	 and	 (3)	 expanded	 analyses	 to	 explore	 sam-
pling	strategies	needed	to	detect	 low	 levels	of	CSF	antibody	
prevalence.
iNTRODUCTiON
Classical	 swine	 fever	 (CSF),	 historically	 called	 hog	 cholera,	 is	
caused	by	CSF	 virus	 (CSFV)	 and	 can	 result	 in	high	morbidity	
and	mortality	 in	swine.	This	disease	 is	reportable	 to	 the	World	
Organization	 for	Animal	Health	 (OIE)	and	viral	detection	can	
severely	diminish	pork	exports.	The	United	States	is	currently	free	
of	CSFV,	with	the	last	reported	case	in	1978	(1).	This	manuscript	
outlines	what	is	known	about	CSFV	and	aims	to	describe	existing	
gaps	in	knowledge.	Additionally,	a	summary	of	vulnerable	sites	of	
CSFV	introduction	into	the	United	States	and	persistence	within	
is	provided.
virus Description
Classical	swine	fever	virus	is	a	small,	enveloped	RNA	virus	that	
belongs	to	the	Flaviviridae	family	and	as	such,	is	closely	related	
to	bovine	viral	diarrhea	virus	(BVDV)	in	cattle	and	border	dis-
ease	virus	(BDV)	in	sheep	(2).	The	genome	contains	12,300	base	
pairs	 and	 comprises	 four	 structural	 and	 seven	 non-structural	
proteins	(3,	4).
Transmission and Clinical Disease
Both	domestic	swine	(and	their	feral	counterparts)	and	wild	suids,	
including	javelina,	bush	pigs,	and	warthogs	are	susceptible	to	CSF.	
Natural	and	experimental	 infections	have	shown	that	 suids	are	
also	capable	of	transmitting	the	virus	(5,	6).	Transmission	routes	
include	oronasal	transmission	through	direct	or	indirect	contact	
with	infected	pigs,	the	consumption	of	feed	contaminated	with	
virus,	or	via	vertical	transmission	from	infected	sow	to	her	off-
spring	(7,	8).	The	virus	is	shed	from	all	mucosal	surfaces	making	
sexual	transmission	a	possibility.	Pork	and	other	pig	products	are	
a	reservoir	for	CSFV	and	survival	may	be	prolonged	in	heavily	
proteinaceous	environments,	especially	that	of	cooled	or	frozen	
meat	products	(9–11).	The	infection	can	cause	a	range	of	clinical	
signs	from	an	inapparent,	subclinical	infection	to	a	hemorrhagic	
fever-like	illness	with	high	mortality	(6).	The	incubation	period	
is	 typically	7–10 days	 following	 infection;	however,	under	field	
settings	it	is	likely	that	a	herd	infection	may	not	be	detected	for	
2–4 weeks,	primarily	because	of	limited	clinical	signs	and	infre-
quent	monitoring	(8).
Classical	 swine	 fever	 strain	 differences	 have	 been	 observed	
and	 attempts	 have	 been	 made	 to	 categorize	 strains	 as	 highly	
virulent	(those	that	kill	nearly	all	pigs	irrespective	of	other	fac-
tors),	moderately	virulent	(those	that	cause	a	sub-acute	illness	in	
postnatally	infected	piglets	and	sometimes	cause	abnormalities	in	
fetuses),	or	avirulent	(those	that	are	attenuated	and	apathogenic	
in	fetuses)	(12).	However,	this	classification	system	is	incongruent	
with	other	findings	where	the	degree	of	pathogenicity	varies	from	
one	pig	to	another	and	is	believed	to	be	a	response	to	host	age	
(and	immune	status),	viral	strain,	and	inoculating	dose	(13,	14).
Very	little	is	known	about	molecular	or	antigenic	properties	
of	 the	virus	 that	 are	 involved	 in	determining	virulence	despite	
numerous	 sequencing	 and	 phylogenetic	 studies;	 however,	
characteristics	have	been	described	in vitro	that	allow	for	some	
viral	 virulence	 determination	 (12,	 15).	 Virulent	 strains	 grow	
optimally	at	39–40°C,	moderately	virulent	strains	grow	optimally	
at	35–38°C,	and	low	virulent	strains	grow	optimally	at	33–34°C.	
Highly	virulent	strains	have	also	been	found	to	grow	faster	and	
to	higher	titers	compared	to	the	other	CSFV	strains	in	cell	culture	
and	are	more	resistant	to	heat	treatment	(12).	Furthermore,	viral	
virulence	 can	 be	 artificially	 abrogated	 using	 laboratory	 tech-
niques	and	specific	proteins	and	post-translational	modifications	
have	 been	 found	 to	 play	 an	 important	 role	 in	 viral	 virulence.	
The	 recoding	 of	 the	 structural	 glycoprotein	 E2	 using	 codon	
usage	deoptimization	has	been	found	to	result	in	complete	virus	
attenuation	and	is	capable	of	protecting	against	a	virulent	CSFV	
challenge	(16).	p7	is	a	non-structural,	hydrophobic	polypeptide	
that,	 through	the	use	of	reverse	genetics,	has	been	found	to	be	
pore-forming	 and	 is	 involved	 in	 viral	 virulence	 (17).	 Finally,	
the	three	glycoproteins	ERNS,	E1,	and	E2	were	evaluated	for	the	
effects	 of	 post-translational	modifications	 and	 those	 that	 were	
not	glycosylated	failed	to	induce	a	detectable	virus	neutralizing	
antibody	 response	 and	 did	 not	 protect	 against	 virulent	 CSFV	
(18).	Despite	our	capacity	to	make	targeted	mutations	that	result	
in	complete	viral	attenuation,	the	exact	properties	that	contribute	
to	viral	virulence	remain	unknown.
Infection	with	CSFV	typically	takes	one	of	three	forms:	acute,	
chronic,	 or	 prenatal	 (8)	 and	 age,	 clinical	 signs,	 and	 disease	
outcome	are	listed	in	Table 1.	Piglets,	less	than	12 weeks	of	age,	
often	develop	an	acute	infection	characterized	by	fever,	anorexia,	
lethargy,	 conjunctivitis,	 respiratory	 signs,	 and	 constipation	 fol-
lowed	by	diarrhea	as	well	as	neurological	signs	that	often	include	
a	staggering	gait,	hind	end	paresis,	ataxia,	and	convulsions.	Death	
follows	1–3 weeks	after	 the	onset	of	clinical	disease	 (19).	With	
increasing	 age	 the	 clinical	 signs	 of	 an	 acute	 infection	 are	 less	
specific	and	recovery	is	possible	(8).	The	chronic	form	develops	
when	pigs	are	unable	to	develop	an	effective	immune	response.	
The	initial	signs	are	similar	to	those	observed	in	the	acute	phase,	
but	as	the	infection	persists	the	clinical	signs	become	nonspecific,	
often	including	intermittent	fever,	chronic	enteritis,	and	wasting.	
Pigs	may	survive	2–3 months	before	succumbing	to	the	infection	
and	 shed	 virus	 consistently	 from	viral	 incursion	 to	 death.	The	
pre-natal	 form	occurs	when	 the	virus	crosses	 the	placenta	and	
infects	 the	 fetus	during	any	stage	of	pregnancy.	Abortion,	still-
births,	mummification,	 and	malformations	 are	 common	when	
TAble 1 | Description of each disease form of CSFV.
Age virulence of 
strain
infection form Clinical signs Disease 
outcome
Reference
<12 weeks
>12 weeks
High
High to moderate
Acute Fever, anorexia, lethargy, conjunctivitis, respiratory signs,  
constipation followed by diarrhea, and neurological signs
Less specific and less severe signs when compared with those in younger animals
Typically death
Recovery is 
possible
(8, 19)
Any age Low Chronic Similar to those in the acute phase but as infection persists, signs become  
non-specific and include intermittent fever, chronic enteritis, and wasting
Typically death (8)
Neonatal 
piglets
Newborn 
piglets
Moderate to low Prenatal (early 
gestation)
Prenatal (days 
50–70 gestation)
Abortion, stillbirth, fetal mummification, and malformations
Normal at birth then begin to show poor growth, wasting, and/or congenital 
tremors
Death (8, 22)
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the	virus	crosses	the	placenta	during	early	pregnancy;	however,	
if	 infected	 50–70  days	 into	 gestation	 the	 piglets	 may	 become	
persistently	infected.	They	often	appear	clinically	normal	at	birth	
and	may	survive	for	several	months	(called	late-onset	CSF)	prior	
to	 showing	 poor	 growth,	 wasting,	 and/or	 congenital	 tremors.	
These	piglets	are	believed	to	be	the	most	important	cause	of	viral	
perpetuation	within	a	population	as	 they	constantly	 shed	 large	
amounts	of	virus	(20).	This	persistently	infected	phenotype	can	
also	 be	 generated	 by	 an	 early	 postnatal	 infection	with	 either	 a	
lowly	or	moderately	virulent	strain	of	CSFV.	While	the	chronic	
and	prenatal	 forms	of	CSFV	are	 always	 lethal	 infections,	 acute	
infections	 with	 CSFV	 are	 not	 always	 lethal	 and	 outcome	 is	
dependent	 upon	 a	 myriad	 of	 factors,	 including	 host	 age	 and	
immune	status,	and	virulence	of	the	acquired	strain,	among	other	
factors	(21).	The	age	component	seems	to	be	an	important	factor	
that	heavily	 impacts	disease	outcome,	with	 the	 same	virus	and	
dose	potentially	resulting	in	a	nearly	asymptomatic	infection	in	
adult	or	breeding	animals	but	may	cause	nearly	70%	mortality	
in	 young	 animals	 (Volker	Moennig,	 Personal	 communication,	
2016).	To	date,	neither	beneficial	nor	detrimental	host	reaction	
patterns	have	been	defined,	suggesting	that	the	outcome	is	largely	
dependent	 on	 the	 immune	 response	of	 the	host,	with	 age	 as	 a	
strong	 factor.	 Additionally,	 differences	 in	 pig	 breed	 have	 been	
evaluated	relative	to	infection	with	CSFV	and	it	was	not	found	
to	be	a	strong	predictor	of	disease	course;	further	suggesting	that	
individual	differences	are	the	main	driver	for	the	clinical	course	
of	infection	(6).
Experimental	 infections	 using	 highly	 virulent,	 moderately	
virulent,	and	lowly	virulent	strains,	classified	as	described	above	
by	van	Oirschot	(12),	demonstrated	that	 the	quantity	of	highly	
virulent	virus	shed	is	far	greater	when	compared	with	either	mode-
rately	or	lowly	virulent	strains	and	is	shed	from	an	earlier	point	
of	infection	(23).	Interestingly,	a	difference	is	not	only	observable	
in	the	timing	and	quantity	of	virus	excreted	but	also	in	the	type	
of	excretions	that	contain	virus.	Highly	virulent	strains	are	shed	
via	all	secretions	and	excretions	while	lowly	virulent	strains	are	
restricted	to	oronasal	secretion	routes.	This	variation	is	thought	
to	be	due	to	viral	tropism.	Highly	virulent	strains	spread	rapidly	
throughout	the	body	whereas	lowly	virulent	strains	are	restricted	
to	specific	target	organs.	Mittelholzer	et al.	(15)	developed	a	clini-
cal	score	scheme	for	CSFV	infections	in	pigs	that	allows	for	the	
quantification	of	observable	clinical	signs	which	includes	10	signs	
that	are	ranked	between	0	(normal)	and	3	(severe	clinical	sign)	
with	a	maximal	score	of	30.	Using	this	clinical	scoring	format	in	
conjunction	with	pyrexia	it	was	found	that	highly	virulent	strains	
have	clinical	signs	>15	and	a	fever	≥41°C,	moderately	virulent	
strains	have	clinical	signs	between	5	and	15	and	a	fever	between	
40	and	41°C,	and	lowly	virulent	strains	have	clinical	signs	below	
2	and	a	fever	≤40°C.
While	limited	data	is	available	for	infection	of	wild	boar	with	
CSFV,	it	is	widely	assumed	that	there	are	no	substantial	differences	
between	domestic	pigs	and	wild	boar	 in	terms	of	susceptibility	
and	clinical	manifestations	(21)	and	the	reports	that	exist	concur	
with	this	assertion.	An	experimental	inoculation	using	Eurasian	
wild	boar	of	various	ages	and	sexes	found	that	the	acute	course	
of	the	disease	was	independent	on	the	origin	of	the	isolate	and	
that	clinical	signs	varied	strongly,	both	of	which	have	been	found	
in	domestic	swine	(24).	Chronically	infected	suids,	those	which	
shed	copious	volumes	of	virus	for	2–3 months	prior	to	succumb-
ing	to	infection,	serve	as	a	reservoir	in	domestic	swine;	however,	
it	is	unknown	if	chronically	affected	wild	boar	could	survive	in	
their	environment,	and	as	such,	how	much	of	a	role	they	may	play	
in	transmission	of	CSFV	(21).	Furthermore,	pregnant	wild	boar	
sows	 infected	during	gestation	were	 found	to	yield	persistently	
infected	 piglets	 (25);	 although,	 the	 role	 congenitally	 infected	
piglets	play	 in	CSFV	 transmission	 in	wild	populations	 is	 likely	
limited	due	to	their	short	survival	time	(26).
Geographical Distribution
Classical	 swine	 fever	 is	endemic	 in	many	parts	of	 the	world	 in	
both	domestic	swine	and	wild	boar.	As	a	reportable	disease,	infor-
mation	on	specific	countries	and	their	annual	CSF	case	load	can	
be	found	at	the	OIE	website	(27).	Canada	and	the	United	States	
are	disease	free	and	have	been	for	50+	and	30+ years,	respectively	
(28).	Mexico	is	recently	disease	free;	however,	Central	America	
(excluding	Panama	and	Belize	which	are	disease	free)	is	endemi-
cally	 infected,	 with	 control	 maintained	 through	 vaccination.	
Much	of	South	America	is	endemically	infected;	however,	coun-
tries	 are	 implementing	 control	 strategies	 such	 as	 vaccination,	
laboratory	 testing,	 stamping	out,	quarantine,	 control	of	 transit,	
and	import	regulations	which	appear	to	be	facilitating	progress	
toward	disease	eradication.	CSFV	is	present	in	Cuba,	Haiti,	and	
the	Dominican	Republic	 and	control	practices	have	been	 tried	
and,	 to	date,	have	 failed	due	 in	 large	part	 to	 a	 lack	of	 funding	
and	institutional	support.	Excluding	Japan,	CSF	outbreaks	occur	
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with	frequency	in	Asia	and	Southeast	Asia,	with	the	largest	viral	
diversity	found	in	these	regions	(1).	Africa	is	believed	to	be	CSF	
free;	however,	Madagascar	has	historically	reported	cases.	West-
ern	 Europe,	 specifically	 European	Union	member	 states,	 have	
sought	progressive	eradication	throughout	the	twentieth	century	
and	vaccination	was	banned	in	1990;	however,	the	region	is	not	
CSFV	free	due	 to	endemic	 infection	 in	wild	boar,	especially	 in	
the	Baltic	states	(Latvia	and	Lithuania),	which	is	transmitted	to	
domestic	pigs	through	direct	or	indirect	contact	or	swill	feeding	
(1,	28,	29).	In	Eastern	Europe,	CSF	remains	a	problem	and	vacci-
nation	in	conjunction	with	stamping	out	is	used	to	curb	outbreak	
events	(1,	28).
In	1997,	there	was	an	outbreak	of	CSFV	in	the	Netherlands	
which	resulted	in	direct	economic	losses	of	$2.3	billion	and	the	
death	of	approximately	9	million	pigs	(30).	The	virus	is	believed	
to	have	entered	 in	mid-late	December	1996,	although	 the	first	
case	of	CSFV	was	not	detected	until	the	middle	of	January	and	
was	not	confirmed	by	laboratory	diagnosis	until	the	beginning	
of	February.	The	primary	case	was	at	a	mixed	sow	and	finishing	
herd	with	nearly	1,500	pigs	of	varying	ages	in	a	very	pig	dense	
region	 of	 the	 country.	 A	 contaminated	 transport	 lorry	 from	
Germany	is	believed	to	have	initiated	the	outbreak	but	the	dis-
ease	quickly	spread	between	farms	in	the	Netherlands	and	was	
exported	 to	 Italy,	 Spain,	 and	 Belgium.	 Routes	 of	 transmission	
that	were	believed	to	play	an	important	role	in	the	outbreak	were	
the	purchase	of	infected	animals,	transport	vehicles,	personnel,	
rendering	 plant	 cadaver	 collection	 service,	 artificial	 insemina-
tion	(contaminated	semen),	pig	slurry,	neighborhood	transmis-
sion,	and	other	unknown	factors;	the	disease	was	re-eradicated	
in	 March	 1998.	 It	 has	 since	 been	 shown	 that	 neighborhood	
transmission	(transmission	between	herds	located	within	several	
kilometers	of	one	another)	presents	a	tremendous	problem	and	
modeling	tools	can	be	used	to	determine	the	risk	of	local	trans-
mission	patterns	(31).
immune Response to CSFv
Classical	 swine	 fever	 virus	 targets	 endothelial	 cells,	 lymphore-
ticular	cells,	macrophages,	and	some	types	of	epithelial	cells	(2).	
Severe	leukopenia	is	a	characteristic	finding	associated	with	the	
early	stages	of	CSFV	infection,	especially	affecting	lymphocytes	
(32).	Reduced	numbers	of	circulating	B cells	(33)	and	CD4+	and	
CD8+	T cells	(34)	have	been	observed	prior	to	the	onset	of	viremia	
and	the	function	of	T cells	isolated	during	a	CSFV	infection	were	
found	 to	 have	 compromised	 function,	which	 is	 believed	 to	 be	
driven	 by	 apoptotic	 events	 (35–37).	 In vitro	 experiments	 have	
demonstrated	 that	 CSFV	 readily	 replicates	 within	 endothelial	
cells	 where	 it	 promotes	 a	 strong	 pro-inflammatory	 and	 pro-
coagulatory	response	(38).	If	a	similar	process	occurs	in vivo	it	is	
suspected	that	the	host	immune	response	plays	an	important	role	
in	the	hemorrhagic	pathogenesis	of	the	disease.	Granulocytopenia	
has	also	been	observed	within	several	days	of	infection	with	CSFV	
in	both	peripheral	and	bone	marrow-derived	neutrophils	which	
is	 thought	 to	be	a	 result	of	hematopoietic	 cell	death	 likely	due	
to	 indirect	 virus-host	 mediated	 mechanisms	 (39).	 Microarray	
analysis	 following	 infection	with	 CSFV	 in	 swine	macrophages	
and	found	79	genes	that	had	altered	patterns	of	expression	within	
48 h	of	infection	(40).	Most	of	the	expression	patterns	that	were	
changed	were	 found	 to	 be	 involved	 in	 the	 development	 of	 the	
innate	immune	response.
In	young	pigs	there	is	a	strong	correlation	between	serum	
IFN-α	 and	 the	 acute	 disease	 process,	 which	 also	 directly	 cor-
relates	to	the	degree	of	 lymphopenia;	thus	suggesting	that	high	
levels	of	IFN-α	do	not	control	the	virus	but,	in	fact,	may	mediate	
immunopathology	 (37).	 The	 release	 of	 pro-inflammatory	 and	
vasoactive	mediators	by	macrophages	 following	 infection	 is	 an	
important	 contributor	 for	 CSFV	 pathogenesis.	 Dendritic	 cells	
are	likely	to	release	pro-inflammatory	cytokines	as	well	as	large	
quantities	of	IFN-α	and	IL-12	which	promotes	TH1	activation.
DOMeSTiC SwiNe iN THe US
The	commercial	production	of	swine	involves	high	biosecurity	in	
a	vertically	integrated	industry	from	farrowing	through	slaugh-
ter	 (National	 Pork	 Producers	 Council,	 Personal	 communication,	
2016)	 A	 majority	 of	 the	 65	 million	 pigs	 in	 the	 United	 States	
are	managed	 indoors	under	 these	conditions	with	 Iowa,	North	
Carolina,	Minnesota,	Illinois,	and	Indiana	boasting	the	top	pork	
production	annually	[Figure 1;	(41)].	Strict	rules	exist	relative	to	
the	management	 of	 animal	 feed,	 transport	 vehicles,	 personnel,	
and	other	fomites	as	a	means	of	preventing	cross-contamination.	
Despite	regimented	biosecurity	practices,	porcine	epidemic	diar-
rhea	virus	entered	the	United	States	in	2013	and	has	since	been	
traced	back	to	contaminated	feed	bags,	suggesting	that	the	com-
mercial	swine	industry	may	not	be	as	refractory	to	pathogens	as	
previously	thought	(42).	This	viral	introduction	and	subsequent	
spread,	suggest	that	viral	stability	plays	a	crucial	role	in	the	effec-
tiveness	of	the	biosecurity	practices	and	highly	stable	pathogens	
may	not	be	adequately	safeguarded	against	(43).
Hobbyists	and	backyard	 farmers	are	 likely	 to	have	domestic	
swine	that	are	not	managed	under	intensive	conditions	and	may	
be	 exposed	 to	 environmental	 elements	 and	 a	number	 of	 other	
species	 (45).	Furthermore,	 it	 is	possible	 that	 their	 feed	may	be	
more	diverse	and	 likely	 involves	 less	oversight	when	compared	
with	commercial	operations.	The	map	of	domestic	pig	production	
in	the	US	depicts	high	densities	of	domestic	swine	and	indicates	
where	a	CSF	introduction	would	likely	be	most	problematic	to	the	
swine	industry	(Figure 1).
eURASiAN wilD bOAR AND CSFv
Native	to	much	of	Europe	and	Asia,	Eurasian	wild	boar	pose	a	
challenge	for	the	control	and	eradication	of	CSFV	in	that	region.	
Experimental	 inoculations	 have	 demonstrated	 that	 they	 are	
acutely	susceptible	to	the	virus	but	their	exact	role	in	maintenance	
or	transmission	events	to	domestic	swine	remains	unknown	(6).	
Large	scale	culling	events	of	domestic	swine	due	to	CSF	occurred	
in	Austria,	Belgium,	the	Czech	Republic,	Germany,	Italy,	Spain,	
and	 the	Netherlands	between	1991	 and	2001.	 It	 has	 been	 sug-
gested	 that	CSF	 in	wild	boar	 is	 associated	with	 the	persistence	
of	 the	 disease	 in	 domestic	 swine,	 although	 viral	 persistence	 in	
either	population	 can	 readily	 be	 transmitted	 to	 the	other	 (46).	
Interestingly,	 serum	 samples	 collected	 from	 259	 wild	 boar	 in	
Croatia	in	2003	found	that	47%	of	the	pigs	sampled	were	positive	
for	the	presence	of	CSFV	antibodies	using	a	highly	specific	ELISA	
FiGURe 1 | Distribution of pig production within the US, 2012 (figure courtesy of: United States Department of Agriculture, National Agricultural Statistics Service 
(44)—used with permission).
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(47).	 There	 was	 a	 statistically	 significant	 difference	 in	 CSFV	
seropositivity	 recorded	between	age	groups	with	pigs	 less	 than	
1 year	having	the	highest	likelihood	of	being	seropositive,	which	
may	be	reflective	of	the	presence	of	maternal	antibodies.	These	
data	suggest	that	the	virus	is	either	being	maintained	within	the	
population	and	infects	the	young	after	maternal	antibodies	wane	
or	that	the	virus	is	being	constantly	reintroduced	from	domestic	
swine	infected	with	CSFV	((47);	Volker	Moennig,	Personal	com-
munication,	2016).
In	France,	wild	boar	were	sampled	between	1992	and	2002	as	
part	of	a	compulsory	monitoring	project	to	track	CSF	infection	
in	the	native	suid	fauna	(48).	Originally	viroprevalence	was	used	
to	 estimate	 incidence;	however,	 low	 incidence	makes	finding	 a	
viremic	animal	very	rare	as	virus	can	only	be	detected	for	a	few	
weeks	following	infection.	Conversely,	antibodies	can	be	detected	
for	 extended	 time	 periods	 following	 infection	 and	 recovery.	
Antibody	prevalence	was	monitored	over	the	ten	year	period	with	
overall	seroprevalence	used	to	estimate	the	proportion	of	immune	
wild	boar,	seroprevalence	in	juveniles	used	to	estimate	the	inci-
dence,	and	seroprevalence	in	different	age	classes	used	to	estimate	
incidence	evolution	in	a	given	cohort.	Spatial	and	temporal	trends	
found	that	after	2000,	no	seropositive	juveniles	were	detected	and	
that	 the	 epizootic	was	 regionally	 extinct.	Using	 seroprevalence	
in	juveniles	to	estimate	incidence	is	likely	an	underestimation	of	
the	true	incidence	as	CSFV	is	acutely	virulent	in	juveniles	such	
that	most	would	die	prior	to	antibody	development;	however,	it	
is	believed	to	be	a	useful	metric	given	the	limitations	associated	
with	sampling	wild	species	and	the	short	duration	of	a	viremia.	
A	capture-mark-recapture	 study	confirmed	 the	above	findings,	
such	 that	 most	 (80%)	 wild	 boar	 piglets	 that	 become	 infected	
with	CSFV	 succumb	 to	 infection	within	 two	weeks	 and	 those	
that	 survive	 infection	 (20%)	 recover	 quickly	 (49).	Host	 innate	
immunological	factors	were	found	to	be	associated	with	fitness	
in	wild	boar,	with	high	complement	activity	associated	with	the	
highest	probability	of	survival	(49).	No	chronic	CSFV	infection	
was	observed	in	wild	boar	piglets	(49).
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Historically,	the	viral	kinetics	of	CSFV	entering	a	naive	wild	
boar	 population	 appear	 to	 proceed	 to	 extinction	within	 a	 few	
years	of	viral	 incursion;	however,	 recent	outbreaks	observed	 in	
France,	 Germany,	 and	 Italy	 were	 characterized	 by	 a	 mortality	
peak	succeeding	the	initial	infection	followed	by	a	slow	progres-
sive	decrease	in	the	infection	rate	over	a	long	time	period	(46).	
Laddomada	(50)	articulated	that	there	are	two	main	factors	that	
contribute	to	either	an	epizootic	event	or	a	persistent,	endemic	
infection:	 (1)	 the	 availability	 of	 susceptible	 animals	 (which	 is	
influenced	by	population	size,	herd	immunity,	and	age	structure	
and	 dynamics)	 and	 (2)	 the	 frequency	 of	 infectious	 contacts	
(which	is	influenced	by	density	and	animal	movements).	Artois	
et al.	(46)	articulate	that	wild	boar	are	unlikely	to	serve	as	a	true	
reservoir	species	because,	(1)	eradication	of	CSFV	from	domestic	
populations	typically	results	in	disease	disappearance	from	wild	
suids,	 (2)	 intentional	 release	 of	 CSFV	was	 performed	 in	 wild,	
free	ranging	boars	and	was	not	 found	to	persist,	and	(3)	when	
appropriate	 epidemiological	 data	 was	 collected	 regarding	 the	
outbreak	among	wild	boars,	human	errors	(feeding,	burying	of	
contaminated	carcasses,	among	others)	were	found	to	be	involved	
in	nearly	every	case.	However,	wild	boar	density	is	important	and	
factors	into	the	role	that	these	native	suids	play	in	viral	mainte-
nance	and	transmission.	In	high	density	regions	the	disease	tends	
to	become	endemic,	whereas	in	lowly	dense	regions	it	often	dies	
out	over	time.	Young	wild	boar	whose	maternal	antibodies	have	
waned	are	believed	 to	be	responsible	 for	 the	majority	of	 trans-
mission	as	older	animals	are	already	immune,	either	as	a	result	
of	 vaccination	or	having	 survived	 a	natural	 infection.	Hunting	
targeted	at	reducing	the	young	wild	boar	population	can	be	used	
to	diminish	the	number	of	susceptible	hosts	which	can	also	be	
useful	in	curbing	an	outbreak	event	(Volker	Moennig,	Personal	
communication,	2016).
Feeding	of	wild	boar	in	Europe	has	risen	in	popularity	which	
results	in	both	more	interaction	among	the	wild	boar	as	well	as	
population	sizes	 that	may	exceed	the	natural	carrying	capacity.	
Factors	particular	to	a	specific	epidemiological	scenario	play	an	
important	role	in	the	capacity	for	wild	boar	to	become	endemi-
cally	infected:	population	density,	frequency	of	interaction,	and	
social	 structure,	 among	others	 (48).	 Furthermore,	 frequent	 re-
introductions	from	infected	domestic	swine	may	give	an	impres-
sion	that	the	disease	has	become	endemic	within	the	wild	boar	
population	(Volker	Moennig,	Personal	communication,	2016).
The	 control	 of	 disease	 in	wildlife	 is	 often	 very	 challenging,	
however,	 vaccines	 can	be	used	 to	 combat	 infectious	disease	by	
decreasing	the	proportion	of	susceptible	animals	below	a	thresh-
old	necessary	for	disease	maintenance	within	the	population	(49).	
The	C-strain	live	attenuated	vaccine	(discussed	in	detail	below)	
has	been	found	to	be	highly	efficacious	and	palatable	baits	have	
been	developed	for	oral	delivery	 in	wild	boar.	In	order	to	curb	
an	outbreak	of	CSFV	in	wild	boar	in	Germany	in	2009,	a	vaccine	
regimen	was	developed	which	involved	three	double	campaigns	
in	spring,	summer,	and	autumn	(51).	The	protocol	was	designed	
to	maximize	both	 antibody	 titers	 and	 the	proportion	of	 vacci-
nated	juvenile	wild	boar,	as	such,	an	initial	bait	was	dropped	fol-
lowed	by	a	booster	28 days	later.	The	C-strain	vaccine	is	derived	
from	a	genotype	1	strain	whereas	the	circulating	field	virus	was	
a	 genotype	 2	 strain;	 thus,	 using	 a	multiplex	 real-time	RT-PCR	
assay	 with	 partial	 sequencing	 assay	 vaccinated	 animals	 could	
be	 differentiated	 from	 those	 naturally	 infected.	 This	 strategy	
depends	on	the	epidemiological	setting	as	regions	with	genotype	
1	viruses	circulating	would	not	be	able	to	use	this	multiplex	assay	
to	differentiate.
Developing	an	oral	bait	that	is	detectable	(odor,	color),	palat-
able	 (odor,	 taste),	and	 that	 is	effectively	 ingested	are	all	 crucial	
components	for	a	successful	mass	oral	vaccination	program	and	
quite	difficult	(49).	Despite	their	omnivorous	diet,	wild	boar	were	
found	to	prefer	baits	containing	plant	derived	compounds	when	
compared	with	animal	derived	compounds.	To	further	complicate	
this	program,	it	 is	necessary	that	the	vaccine	be	released	in	the	
oral	cavity	such	that	the	tonsils	can	initiate	the	immune	response.	
The	vaccine	must	be	perforated	by	pig	teeth	prior	to	swallowing;	
bait	size	is	crucial	as	too	small	will	likely	be	swallowed	prior	to	
perforation	 and	 too	 big	will	 limit	 the	 number	 of	 animals	 that	
uptake	the	vaccine.	Field	trials	were	first	performed	in	Germany	
in	 the	1990s	and	were	 then	deployed	 to	other	European	coun-
tries	during	 the	2000s.	Prebaiting,	 the	practice	of	 accustoming	
wild	boar	to	the	bait	prior	to	vaccine	distribution,	was	found	to	
be	 necessary	 and	 the	 vaccine	 bait	was	 delivered	 by	 hunters	 to	
account	for	wild	boar	foraging	which	occurs	in	groups,	such	that	
concentrating	baits	in	feeding	places	was	far	more	effective	when	
compared	with	random	distribution	by	aircraft.
DiAGNOSTiCS
The	diagnosis	of	CSF	 typically	 consists	of	 four	complementary	
elements	 (although	 all	 four	 are	 not	 always	 detectable)	 which	
include	 field	 clinical	 signs,	 gross	 pathology	 findings,	 indirect	
detection	(serology),	and	direct	detection	(virus	isolation	or	anti-
gen	or	nucleic	acid	detection)	(52).	Live	virus,	as	well	as	RNA,	can	
be	detected	from	blood,	tonsil	swabs,	or	tissues	upon	necropsy	
(19).	Samples	collected	from	live	animals	should	be	taken	when	
the	animal	is	pyrexic	as	it	substantially	increases	the	probability	
of	viral	detection.	The	OIE	manual	recognizes	a	myriad	of	assays	
as	 acceptable	means	 for	 detecting	CSFV,	 such	 as	 a	 fluorescent	
antibody	 test,	 immuno-peroxidase	 staining,	 antigen	 capture	
ELISA,	virus	isolation	in	cell	culture,	and	RT-PCR;	some	assays	
are	designed	to	evaluate	live	virus	or	viral	particles	while	others	
detect	CSFV-specific	antibodies	(19,	53–55).
Antibodies	 are	 first	 detectable	 2–3  weeks	 following	 initial	
infection	and	often	persist	for	the	duration	of	the	life	of	the	pig	
(52).	Serological	assays	are	highly	useful	for	both	diagnostics	and	
surveillance	 and	 the	 OIE	 recommends	 a	 fluorescent	 antibody	
neutralization	test,	a	neutralizing	peroxidase	linked	assay,	or	an	
antibody	ELISA	(55).	Viral	neutralization	assays	are	regarded	as	
the	“gold	standard”	but	they	are	labor	intensive	and	require	cell	
culture	 capabilities,	which	are	not	 always	 available.	ELISAs	 for	
CSFV	diagnosis	are	typically	designed	for	the	E2	glycoprotein	and	
this	assay	type	is	heavily	used	as	a	screening	tool	for	antibodies	
during	and	after	outbreaks,	monitoring	CSFV	infection	in	wild	
boar	populations,	and	to	evaluate	vaccine	coverage	following	an	
oral	administration	in	wild	pigs	(52).	Despite	widespread	use,	the	
majority	of	well-established	traditional	assays	used	to	detect	CSF	
virus	or	antibodies	are	not	validated	by	OIE	standards	as	the	first	
chapter	outlining	methods	of	validation	for	diagnostic	assays	was	
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not	published	until	1996	(55).	It	is	important	to	note	that	antibod-
ies	for	both	BVDV	and	BVD	can	cross	react	with	CSFV-specific	
antibodies	and	in	some	cases,	serological	assays	may	provide	an	
inaccurate	read	unless	specifically	guarded	against	(56).
vACCiNeS
Currently,	 multiple	 live	 attenuated	 vaccines	 are	 commercially	
available	and	have	been	found	to	be	safe	and	highly	efficacious	
against	 infection	 with	 CSFV	 (57).	 As	 an	 example,	 the	 lapin-
ized	Chinese	vaccine	(C-strain)	was	developed	 in	 the	1950s	by	
Chinese	 researchers	 and	 has	 been	 used	 extensively	 to	 control	
CSF	 in	China	 and	many	 other	 countries	 (58).	Despite	 provid-
ing	sterilizing	immunity	to	nearly	all	vaccinees	within	one	week	
of	 vaccine	 administration,	 current	 live	 attenuated	 vaccines	 for	
CSF	have	a	major	disadvantage:	 it	 is	 impossible	 to	differentiate	
between	naturally	 infected	 and	 vaccinated	 animals	 using	 sero-
logical	methods	(55,	59).	This	is	concerning	as	vaccines	are	being	
used	to	supplement	other	control	methods	and	viral	transmission	
cannot	be	effectively	modeled	due	to	the	lack	of	assays	capable	
of	 differentiating	 between	 vaccinated	 and	 infected	 animals.	
However,	Zhao	et al.	(58)	describe	a	multiplex	real-time	RT-PCR	
assay	that	is	both	rapid	and	sensitive	for	differentiating	between	
wild-type	viruses	and	 the	C-strain	vaccine	 for	CSFV	in	China.	
This	assay	is	only	applicable	for	C-strain	based	vaccines,	and	is	
not	capable	of	distinguishing	between	other	exotic	vaccines;	with	
further	work,	 it	 remains	a	possibility	 that	differentiating	assays	
may	 become	 available	 for	more	 live	 attenuated	CSFV	 vaccines	
that	work	on	a	global	scale.
As	a	means	of	circumventing	the	primary	concern	associated	
with	live	attenuated	vaccines,	several	other	vaccine	strategies	have	
been	employed,	 such	as	 the	generation	of	 immunogenic	CSFV	
particles,	DNA	vaccines,	viral	vectors	expressing	CSFV	proteins,	
chimeric	 pestiviruses,	 and	 trans-complemented	 deleted	 CSFV	
genomes	 (57).	These	 novel	 vaccines	 require	 a	myriad	 of	 doses	
and	dosages	to	attain	various	levels	of	protection	against	CSFV	
challenge.	E2	has	been	found	to	be	a	highly	antigenic	envelope	
glycoprotein	 that	can	be	expressed	using	a	baculovirus	expres-
sion	system	and	has	been	found	to	induce	a	neutralizing	antibody	
response	in	pigs	(60,	61).	Importantly,	animals	vaccinated	with	
the	recombinant	E2	vaccine,	also	referred	to	as	a	subunit	vaccine,	
can	be	readily	differentiated	from	those	naturally	infected	as	the	
latter	will	generate	a	polyclonal	response	that	involves	E2	in	addi-
tion	 to	NS3	 and	ERNS	whereas	 vaccinated	 animals	will	 develop	
a	monoclonal	 response	 against	 E2	 exclusively	 (62).	 An	 ELISA	
has	been	developed	that	detects	ERNS	and	can	effectively	be	used	
to	 differentiate	 samples	 from	 vaccinated	 and	 infected	 animals	
(55,	63).	Two	E2	vaccines	are	currently	licensed	by	the	European	
Agency	for	the	Evaluation	of	Medicinal	Products	and	commer-
cially	 available	 despite	 the	 higher	 risk	 of	 persistently	 infected	
animals	and	the	need	for	increased	caution	with	pregnant	sows	
(63).	In	addition	to	the	subunit	E2	vaccines,	chimeric	pestivirus	
vaccines	have	been	evaluated	and	promising	results	were	found	
for	CP7_E2	alf	(which	is	a	BVDV	backbone	expressing	the	CSFV	
E2	glycoprotein)	and	flc11	(a	CSFV	backbone	with	the	ERNS	gene	
replaced	 by	 the	 corresponding	 BVDV	 gene)	 (64).	 Both	 of	 the	
aforementioned	 pestivirus	 candidates	 were	 comparable	 to	 the	
C-strain	vaccine	and	upon	early	challenge,	CP7_E2	alf	was	found	
to	be	better	for	safety	and	efficacy	following	oral	administration.	
The	marker	concept	has	been	demonstrated	but	the	discrimina-
tory	assays	require	further	optimization.
Field	efficacy	of	the	CP7_E2	alf	vaccine	was	evaluated	using	
experimental	infections	of	both	Eurasian	wild	boar	and	domestic	
swine	(65).	Following	vaccination,	experimental	domestic	swine	
or	 wild	 boar	 are	 typically	 challenged	 with	 a	 CSFV	 genotype	
1.1	strain,	which	represents	a	homologous	virus	 to	 the	vaccine	
strain	but	is	unlikely	to	be	reflective	of	circulating	field	isolates.	
Vaccination	with	CP7_E2	alf	followed	by	challenge	with	virulent	
CSFV	genotypes	 2.1	 and	2.3	 led	 to	 complete	protection	which	
affirms	the	field	applicability	of	the	chimeric	pestivirus	vaccine.	
Furthermore,	longevity	of	immunity	studies	were	undertaken	to	
evaluate	 the	 duration	 of	 protection	 following	 vaccination	with	
CP7_E2	 alf	 followed	 by	 infection	with	 a	 virulent	 CSFV	 strain	
(66).	Domestic	swine	were	vaccinated	orally	or	via	intramuscular	
injection	with	CP7_E2	alf	and	challenged	with	a	virulent	CSFV	
strain	 six	 months	 following	 vaccination.	 Antibody	 titers	 were	
stable	for	the	duration	of	the	6 months	irrespective	of	the	route	of	
vaccination	and	high	antibody	titers	lead	to	full	virus	neutraliza-
tion	and	full	protection	following	lethal	challenge	was	observed.	
One	 non-responder	 was	 observed	 following	 oral	 vaccination,	
suggesting	 that	 the	 oral	 route	 of	 vaccination	 leads	 to	 a	 more	
variable	 response.	The	CP7_E2	 alf	 vaccine	 is	 a	 very	promising	
prophylactic	and	its	capacity	to	be	differentiated	from	a	natural	
infection	provides	a	tremendous	advantage.	This	vaccine	is	cur-
rently	licensed	by	the	European	Medicines	Agency.
CSF AND THe UNiTeD STATeS
The	domestic	 swine	 industry	 in	 the	United	States	would	 likely	
be	very	negatively	impacted	in	the	event	of	CSFV	introduction.	
Passive	and	active	surveillance	programs,	defined	as	using	reports	
and	 testing	 of	 animals	 found	 dead	 and	 developing	 a	 program	
to	 capture	 animals	 in	 some	 way	 (live-capture,	 hunter	 harvest,	
euthanasia)	for	testing,	respectively	(67),	exist	for	both	domestic	
and	feral	swine.	USDA	Veterinary	Services	have	outlined	a	sur-
veillance	program	for	domestic	swine	and	the	objectives	are	as	
follows:	(1)	surveillance	for	rapid	detection	of	CSFV	in	US	swine,	
(2)	monitor	 the	risk	of	 introduction	of	CSF	 into	US	swine,	 (3)	
surveillance	of	international	CSF	status,	and	(4)	surveillance	to	
document	freedom	of	CSF	(68).	Passive	surveillance	is	performed	
in	 all	 states	 and	 requires	 involvement	by	producers,	diagnosti-
cians,	and	slaughterhouse	inspectors,	among	others	to	report	and	
sample	any	suspect	cases.	Unthrifty	pigs,	considered	to	be	those	
that	 gain	weight	 poorly	 or	 are	 otherwise	 somewhat	 sickly,	 are	
often	sold	to	off	market	vendors	and	APHIS	field	staff	or	other	
cooperating	personnel	collect	tonsil	samples	in	these	markets	as	a	
way	to	survey	for	infectious	agents,	including	CSFV.	This	method	
is	deemed	to	be	an	effective	surveillance	strategy	as	pigs	from	sur-
rounding	regions	are	often	consolidated	in	these	markets	which	
makes	for	an	efficient	means	of	sampling	sickly	pigs	from	a	wider	
geographical	area.	Furthermore,	high	risk	areas,	which	 include	
regions	with	garbage	feeding	operations,	backyard	swine	opera-
tions,	feral	swine	hunting	clubs,	military	bases,	international	air	
or	sea	ports,	farming	operations	utilizing	an	international	labor	
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force,	 and/or	 corporations	 engaging	 in	 international	 swine	
movement,	are	subject	to	active	surveillance	protocols;	25	states	
are	 considered	 high-risk.	 All	 garbage	 feeder	 operations	 in	 the	
United	States	are	licensed	and	regularly	inspected	and	heat	treat-
ment	of	all	feed	is	mandatory.	Texas	and	Florida	are	considered	
particularly	high	risk	and	as	such,	two	swine	slaughter	establish-
ments	in	Florida	and	three	in	Texas	randomly	collect	blood	which	
is	sent	to	the	Foreign	Animal	Disease	Diagnostics	Laboratory	for	
further	 testing,	especially	 from	pigs	 in	 the	southern	portion	of	
each	state,	light	weight	pigs,	or	those	in	transition.
Feral	 swine	 are	 also	 surveyed	 as	 a	 preventative	 and	 early	
sentinel	 in	 the	 event	 of	 a	 CSFV	 intrusion.	 Feral	 animals	 are	
typically	 referred	 to	 those	 who	 have	 been	 phenotypically	
selected	by	humans	but	do	not	 live	under	human	supervision	
or	 control	 (69).	 Feral	 swine	 (Sus scrofa)	 describe	 a	 genotypi-
cally	diverse	composite	of	suids	that	include	escaped	domestic	
swine,	 truly	 wild	 Eurasian	 boars,	 and	 their	 hybrids	 (70,	 71).	
There	are	ongoing	surveillance	programs	for	CSFV	antibodies	
in	feral	swine	and	targeted	areas	typically	include	domestic	hog	
production	 areas	 and	 landfills.	 Counties	 are	 weighted	 based	
on	 the	 presence	 or	 absence	 of	 each	 of	 the	 aforementioned	
criteria	 (72).	This	 type	 of	 targeted	 surveillance	 increases	 the	
probability	 of	 early	 detection	 in	 the	 event	 of	 virus	 introduc-
tion	 (73,	 74).	 Samples	 are	 collected	 via	 culling	 operations	 as	
well	 as	 from	 hunter-killed	 pigs	 and	 serology	 is	 performed	 to	
evaluate	 the	 presence	 of	 CSFV	 antibodies.	 Serological	 assays	
are	 used	 in	 series,	 beginning	with	 an	 ELISA,	 followed	 by	 an	
immunoperoxidase	 test,	 and	 finally	 virus	 neutralization.	
As	 soon	 as	 a	 sample	 tests	 negative,	 it	 is	 no	 longer	 assayed	
(e.g.,	if	a	sample	is	negative	at	the	ELISA	it	is	not	tested	by	immu-
noperoxidase	or	virus	neutralization).	This	series	of	diagnostic	
assays	exists	as	antibodies	against	BVDV	and	BDV	cross	react	
with	CSFV	which	may	result	in	a	false-positive	reading;	thus,	the	
downstream	diagnostics	are	increasingly	specific.
In	addition	to	domestic	and	feral	swine	surveillance	efforts,	
plans	have	been	developed	in	the	event	of	viral	incursion	(75).	
The	primary	document	outlines	the	four	key	outbreak	strategies:	
(1)	stamping	out,	which	involves	depopulating	clinically	affected	
animals	and	in-contact	susceptible	animals;	(2)	stamping	out	with	
emergency	vaccination	to	kill,	in	which	clinically	affected	and	in-
contact	susceptible	animals	are	depopulated	and	at-risk	animals	
are	vaccinated	and	subsequently	depopulated	and	disposed	of;	
(3)	 stamping	 out	 with	 emergency	 vaccination	 to	 slaughter,	 in	
which	clinically	affected	and	in-contact	susceptible	animals	are	
depopulated	and	at-risk	animals	are	vaccinated	and	slaughtered	
and	processed;	or	 (4)	 stamping	out	with	emergency	vaccina-
tion	 to	 live,	 which	 involves	 depopulating	 clinically	 affected	
animals	 and	 in-contact	 susceptible	 animals	 and	 vaccinating	
at-risk	animals	whence	they	are	not	depopulated.	Multiple	factors	
influ	ence	the	response	strategy,	including	scale	of	the	outbreak,	
outbreak	consequences,	acceptance,	available	veterinary	coun-
termeasures,	and	available	resources	for	implementing	response	
strategies.	A	detailed	approach	is	also	needed	on	how	to	provide	
relevant	information	to	responders	and	stakeholders	during	an	
outbreak	(76).
The	United	 States	 also	 harbors	 a	 supply	 of	CSFV	 vaccines	
at	 the	 National	 Veterinary	 Stockpile.	The	US	maintains	 both	
the	C-strain	 live	attenuated	vaccine	as	well	 as	 the	CP7_E2	alf	
vaccine	(Personal	communication,	2016).	The	C-strain	vaccine	
has	been	used	extensively	in	control	and	eradication	programs	
in	many	countries	throughout	the	world	and	its	efficacy,	safety,	
onset	of	immunity,	duration	of	immunity,	and	many	other	fac-
tors	are	well	characterized	in	the	field.	The	CP7_E2	alf	vaccine	
has	been	used	to	a	much	lesser	extent	in	field	applications	and	
performance	 is	 less	well	 characterized.	Each	product	 requires	
one	vaccination	 to	 result	 in	 sterilizing	 immunity;	however,	 as	
discussed	 above	 in	 the	 vaccine	 section,	 antibodies	 generated	
in	 response	 to	 vaccination	 with	 the	 C-strain	 vaccine	 cannot	
be	 differentiated	 from	 those	 developed	 by	 animals	 who	 are	
naturally	 infected	whereas	 the	 CP7_E2	 alf	 vaccine	 allows	 for	
differentiation.
SUMMARY OF vUlNeRAbiliTieS FOR 
THe iNTRODUCTiON OR PeRSiSTeNCe 
OF CSFv iN THe US
Risk of introduction into the United States 
The	legal	movement	of	live	animals	or	their	products,	byproducts,	
or	 animal	 feed,	 the	 illegal	movement	of	 live	 animals	 and	 their	
products,	 or	 an	 intentional	 viral	 release	 in	 an	 act	 of	 bioterror-
ism	are	all	channels	through	which	a	disease	outbreak	of	CSFV	
is	 likely	 to	occur.	These	routes	are	 the	most	probable	means	of	
introduction	due	to	patterns	of	virus	transmission,	viral	stability,	
and	 current	 global	 instability.	 Each	 of	 these	 possible	 routes	 of	
introduction	are	displayed	in	Figure 2	and	described	in	detail	in	
this	section.
Legal Movement of Live Animals
In	 2015,	 the	 only	 live	 swine	 imports	 into	 the	 United	 States	
(domestic	 or	 exotic/wild	 species)	 came	 from	Canada	 in	which	
just	under	6	million	pigs	were	 imported	 for	breeding,	 feeding,	
or	direct	to	slaughter.	Canada	is	CSFV	free	so	it	is	unlikely	that	a	
live	pig	imported	from	the	northern	border	would	be	responsible	
for	a	viral	incursion.
Legal Movement of Animal Products, Byproducts, 
and Animal Feed
A	number	of	animal	products,	byproducts,	and	feed	are	imported	
into	 the	 United	 States	 annually	 and	 permits	 are	 required.	
Treatments	typically	involving	heat,	pH,	or	fixation	processes	are	
required	for	all	animal	products	and	byproducts	 that	are	being	
imported	from	CSF-endemic	regions.	Unprocessed	products	are	
permitted	for	entry	from	CSF-free	countries.	Specific	temperature	
and	duration	cooking	is	required	for	animal	feed	imported	from	
countries	 endemic	 for	CSF.	The	European	Union	 is	designated	
as	a	low-risk	region	and	as	such,	products	can	be	imported	raw;	
although	documentation	is	required	to	certify	that	the	product	is	
coming	from	an	unaffected	herd	in	an	unaffected	region.
Illegal Movement of Live Animals and Their Products
The	 risk	 of	 virus	 introduction	 through	 illegal	 transport	 of	 live	
animals	 and	 their	 products	 is	 related	 to	 the	 types	 of	 products	
being	moved,	and	their	country	of	origin	and	final	destination.	
FiGURe 2 | A schematic diagram depicting the potential sources of a classical swine fever virus (CSFV) incursion into the US and the consequences of feral swine 
involvement.
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The	US	Department	of	Homeland	Security	Customs	and	Border	
Protection	 (CBP)	 confiscates	 products	 and	 specimens	 from	
domestic	animals	in	the	cargo	and	express	courier	environments.	
More	 than	 68,000	 products	 and	 specimens	 were	 confiscated	
by	CBP	between	2012	and	2016	and	over	90%	of	confiscations	
were	of	products	originating	in	Asia	and	Europe.	These	findings	
confirm	that	illegally	imported	products	and	specimens	serve	as	
a	route	 for	CSFV	introduction	as	Asia	and	parts	of	Europe	are	
endemic	for	the	virus.
The	 confiscation	 of	 illegally	 imported	 wildlife	 and	 their	
products	fall	under	the	jurisdiction	of	the	US	Fish	and	Wildlife	
Service.	 Between	 2006	 and	 2016,	 133	wild	 suid	 products	were	
confiscated	 and	 the	majority	of	 the	products	 seized	were	 from	
Africa.	It	is	important	to	note	that	a	tiny	fraction	of	all	illegally	
imported	 wildlife	 shipments	 are	 believed	 to	 be	 detected	 (77);	
thus,	these	numbers	likely	represent	a	gross	underestimation.
Bioterrorism
Classical	swine	fever	virus	is	a	bioterrorism	candidate	because	of	
the	 tremendous	 economic	value	of	 the	domestic	 swine	 industry	
in	 the	United	 States,	 the	 clinical	 disease	 associated	with	 infec-
tion,	the	endemic	status	of	many	countries	globally	making	viral	
acquisition	a	ready	option,	the	robust	stability	of	the	virus	in	a	
proteinaceous	 environment	 and	 the	 crippling	 implications	 for	
international	 trade.	As	such,	domestic	and	 feral	 swine	must	be	
surveyed	for	disease	frequently	and	systems	for	rapid	diagnosis	
must	be	readily	available.
Factors That Complicate eradication 
efforts following introduction
Feral	swine	are	found	in	 large	numbers	across	much	of	the	US	
and	their	highly	flexible	diet,	interaction	with	domestic	pigs,	and	
unmanaged	lifestyle	make	them	an	opportune	vector	for	further	
disease	transmission	following	an	introduction	event.	In	the	event	
of	a	viral	incursion	feral	swine	could	contribute	to	amplification	
and	 transmission	events	 to	other	 feral	 swine	or	 their	domestic	
counterparts	and	would	serve	to	significantly	complicate	disease	
control	measures	(78).
Feral Swine
Feral	swine	include	released	domestic	swine,	truly	wild	Eurasian	
boar,	and	their	hybrids	(79).	Nearly	6	million	feral	swine	roam	the	
US	and	are	believed	to	be	 found	in	at	 least	35	states.	They	have	
been	shown	to	carry	a	wide	variety	of	pathogens	capable	of	infect-
ing	domestic	livestock	(80)	and	GPS	data	has	shown	feral	swine	
interacting	with	domestic	swine	(45).	These	types	of	interac	tions	
increase	the	risk	of	pathogen	transmission	from	feral	to	domestic	
swine.	 Alternatively,	 the	 evaluation	 of	 interspecies	 interactions	
using	GPS	and	proximity	 loggers	between	cattle,	domestic	pigs,	
Eurasian	wild	boar,	and	red	deer	found	very	limited	interactions	
between	 wildlife	 and	 livestock	 (81),	 although	 feral	 swine	 may	
not	behave	as	Eurasian	wild	boar	relative	to	their	social	behavior.	
Peccaries	are	not	included	as	a	risk	as	they	are	not	believed	to	be	
important	for	virus	maintenance	and	transmission	(82).
While	 domestic	 swine	 are	 likely	 the	 higher	 risk	 group	 for	
acquiring	 CSF,	 it	 is	 important	 to	 note	 that	 feral	 swine	 could	
participate	 in	a	CSFV	outbreak	 in	the	US	in	one	of	 the	several	
ways.	Feral	swine	regularly	are	found	scavenging	in	landfills	and	
consumption	of	CSFV-contaminated	garbage	(e.g.,	airport	waste)	
could	lead	to	an	introduction	event	directly	into	feral	swine.	The	
index	 feral	 swine	could	 then	 infect	other	 feral	 swine	as	well	as	
domestic	pigs,	particularly	 those	housed	 in	a	backyard	 setting.	
Alternatively,	 some	 domestic	 pigs	 are	 fed	 swill	 and	 illegally	
imported	 or	 improperly	 treated	 swill	 could	 result	 in	 a	 CSFV	
introduction	 directly	 into	 domestic	 swine	 which	 could	 then	
spillover	into	feral	swine.
As	described	previously,	feral	swine	are	routinely	culled	and	
samples	are	collected	as	part	of	an	active	surveillance	program	
to	ensure	rapid	detection	and	diagnosis	in	the	event	of	a	CSFV	
incursion.	 Swafford	 et  al.	 (83)	 published	 antibody	data	 against	
CSFV	in	feral	swine	and	found	that	no	antibodies	were	detected	
in	 collection	 years	 2007	 and	 2008.	 In	 fact,	 no	 CSFV-specific	
Distant 
sounder
Infected 
premise
Direct 
contact 
sounder
Lone 
boar
Direct 
contact 
sounder
FiGURe 3 | Example illustration of how disease management may be 
approached in a feral population. It is important to note that this graphic is 
not drawn to scale (e.g. sounders contain more pigs but have smaller ranges 
when compared with lone boars) and that all of the groups depicted in this 
graphic are dynamic and in constant movement.
10
Brown  and Bevins Potential Transmission of CSFV
Frontiers in Veterinary Science | www.frontiersin.org March 2018 | Volume 5 | Article 31
antibodies	have	been	detected	in	feral	swine	since	the	inception	
of	the	program	through	the	current	day	(Kerri	Pedersen,	Personal	
communication,	 2016).	 In	 the	 event	 of	 a	 CSFV	 introduction,	
large	sample	sizes	are	required	to	detect	low	prevalence	patho-
gens	and	sampling	on	a	country-wide	scale,	with	a	feral	swine	
population	 exceeding	 6	million	 animals,	would	 necessitate	 an	
extremely	large	sample	size	and	subsequently,	a	substantial	and	
sustained	economic	 investment.	Simulation	models	conducted	
in	Germany	demonstrated	that	the	financial	resources	and	per-
sonnel	necessary	for	reliable	testing	are	substantial	and	difficult	
to	sustain	over	time.	In	addition,	sufficient	sample	sizes	to	detect	
low	virus	prevalence	are	difficult	to	obtain	(84).	Large	and	costly	
efforts	would	be	needed	to	test	a	statistically	significant	portion	
of	the	population,	which	would	require	significant	funding	and	
a	continuous	effort	over	time.
Disease-emergence	dynamics	modeled	in	feral	swine,	a	highly	
gregarious	and	social	species	(85),	demonstrated	that	under	real-
istic	 demographics	 and	 contact	 structure,	 a	CSFV-like	disease	
could	persist	 for	 long	periods	of	 time	resulting	 in	many	more	
cases	(78).	These	data	are	in	agreement	with	a	model	that	demon-
strated	that	CSFV	in	wild	pigs	in	Australia	was	able	to	both	persist	
and	spread	across	the	landscape	(86).	These	findings	support	the	
assertion	that	feral	swine	present	a	concern	for	viral	incursion	
because	of	their	behavior—omnivorous	and	opportunistic	diets,	
close	 social	 interaction,	 and	unmanaged	movement—and	 that	
despite	 active	 surveillance	 efforts,	 infection	may	 remain	 silent	
until	a	substantial	portion	of	the	population	displayed	antibody	
presence	or	morbidity	or	mortality	events.	However,	introduc-
tion	of	CSFV	into	a	naive	population	is	often	accompanied	by	
high	morbidity	 and	mortality	 as	 observed	 by	 the	 detection	of	
an	 increase	 in	 the	 number	 of	 dead	 animals	 on	 the	 landscape,	
which	would	presumably	be	detected	and	 investigated	by	field	
biologists	(87).
Disease	transmission	modeling	in	feral	swine	must	account	
for	their	social	activities	and	lifestyles.	Sounders	are	comprised	
of	 reproductively	 active	 females	 and	 their	 young	while	males	
typically	 live	 a	 solitary	 life.	GPS	 data	 has	 shown	 that	 contact	
rates	 are	 much	 higher	 for	 animals	 within	 the	 same	 sounder	
when	 compared	 with	 those	 animals	 in	 different	 sounders	
(88).	 Sounder	 interaction	 is	 reduced	 at	 distances	>2  km	 and	
disease	transmission	is	also	expected	to	be	reduced	(89).	These	
findings	 suggest	 that	 the	 quarantine	 surrounding	 a	 positive	
premise	should	be	at	 least	2 km.	Importantly,	 lone	boars	 tend	
to	have	much	larger	home	ranges	(90)	which	could	complicate	
quarantine	 and	 surveillance	 efforts	 in	 the	 event	 of	 a	 disease	
outbreak.	 It	 is	 important	 to	 note	 that	 under	 the	 assumption	
that	 transmission	of	CSFV	among	wild	boar	occurs	primarily	
through	 direct	 contact,	 CSF	 incidence	 should	 increase	 with	
increasing	host	density	and	should	go	extinct	under	a	threshold	
density	of	susceptible	hosts.	Interestingly,	however,	analysis	of	
the	incidence	and	viral	persistence	of	CSF	in	the	French	Vosges	
Forest	 demonstrated	 that	 infection	 depressed	 density	 but	 did	
not	support	the	hypothesis	of	density	dependence	of	incidence	
(91).	This	suggests	that	the	presence	of	circulating	CSFV	reduced	
the	population	of	wild	boar	but	that	viral	transmission	was	not	
strictly	density	dependent.	However,	these	findings	may	not	be	
representative	of	all	ecological	settings	as	density	has	appeared	
to	be	a	crucial	factor	for	CSFV	transmission	in	a	multitude	of	
other	studies	(2,	8,	21).
Feral	swine	are	of	tremendous	concern	in	the	event	of	disease	
outbreaks	 that	affect	domestic	 livestock.	Hog	panels	have	been	
evaluated	and	can	effectively	contain	feral	swine	(92).	Although	
relatively	cheap	and	quick	to	erect,	fencing	is	only	a	viable	option	
to	control	movement	of	feral	swine	on	a	small	scale.
Targeted	culling	of	young	wild	boar	would	likely	not	be	effica-
cious	in	the	United	States	to	curb	an	outbreak	as	the	entire	US	
feral	swine	population	is	susceptible	to	infection	with	CSFV	when	
compared	with	the	scenario	in	Western	Europe	where	older	ani-
mals	are	typically	immune	as	a	result	of	vaccination	or	a	survived	
infection	with	CSF.
In	many	instances	in	the	United	States,	vaccination	of	suscepti-
ble	animals	following	the	introduction	of	a	foreign	animal	disease	
is	not	a	viable	option	for	a	myriad	of	reasons;	however,	it	could	
be	an	option	in	the	event	of	a	widespread	outbreak.	Vaccination	
using	oral	baits	would	be	a	potential	strategy	to	curb	an	outbreak	
in	feral	swine	as	they	have	been	used	very	effectively	in	Eurasian	
wild	boar	in	the	European	Union.
Outbreak	specific	characteristics	would	be	important	to	include,	
such	as	the	amount	of	time	that	has	elapsed	since	the	first	case,	
the	virulence	of	the	CSFV	strain,	the	density	of	both	domestic	and	
feral	swine,	among	many	other	components.	Multiple	control	and	
mitigation	strategies	could	be	employed	in	the	event	of	a	foreign	
animal	disease	introduction	that	may	have	spilled	over	into	feral	
swine	populations	(Figure 3).
Sounders	that	are	in	direct	contact	with	swine	from	the	infected	
premise	(“direct	contact	sounders”)	are	included	as	well	as	“dis-
tant	sounders”	which	are	likely	to	interact	with	“direct	sounders.”	
A	 lone	boar	 is	also	 included	 in	 this	depiction	and	often	have	a	
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much	 larger	 home	 range	 when	 compared	 with	 sounders;	 they	
are	likely	to	be	interacting	with	domestic	swine	on	the	infected	
premise,	“direct	contact	sounders,”	and	“distant	sounders,”	as	well	
as	sounders	that	exist	outside	of	this	graphic	and	other	boars.	The	
exact	distance	of	the	perimeter	fencing	(demarked	as	black	dotted	
lines)	would	be	determined	based	on	factors	related	to	sounder	
home	 range,	 the	 environment,	 and	 pathogen	 specific	 compo-
nents;	 however,	 the	 below	 diagram	 provides	 insight	 into	 how	
disease	management	may	be	 approached	 in	 a	 feral	 population.	
A	double	perimeter	 fence	would	be	 employed	as	CSFV	can	be	
readily	transmitted	by	direct	contact;	thus,	it	would	be	essential	to	
prevent	feral	swine	within	the	quarantine	region	from	interacting	
with	feral	swine	outside	the	quarantine	region.	The	graphic	has	
been	simplified	to	include	only	one	infected	premise	within	the	
quarantine	area;	however,	this	is	unlikely	to	be	accurate	in	rural	
regions	of	the	United	States	where	hobby	farms	are	abundant.
Disease	surveillance	in	feral	and	wild	animals	is	challenging	
for	a	number	of	 reasons	and	control	and	eradication	measures	
are	abundantly	complicated.	Resource	allocation	and	a	systemic	
perspective	 is	 useful	 when	making	 important	 decisions	 in	 the	
absence	 of	 information	 (93).	Currently	 both	 the	 northern	 and	
southern	borders	 in	the	United	States	are	porous,	which	in	the	
event	of	a	CSFV	introduction	into	either	Canada	or	Mexico,	the	
fluidity	of	 feral	 swine	moving	 across	 the	border	 region	will	 be	
challenging.
CONClUDiNG ReMARKS
Due	 to	 the	 severe	morbidity	and	mortality	 caused	by	CSFV	 in	
domestic	 swine,	 introduction	 (either	 accidental	 or	 purposeful)	
presents	a	risk	to	the	United	States.	Federal	oversight	is	provided	
for	the	importation	of	live	animals	and	their	products	and	com-
prehensive	mitigation	strategies	are	mandated	for	products	origi-
nating	in	CSFV-endemic	countries.	Despite	these	safeguards,	the	
illegal	 importation	of	 animals	 and	 their	 products	 is	 an	 avenue	
that	is	inherently	unrestricted;	thus,	serves	as	a	viable	route	for	
viral	introduction.	An	act	of	bioterrorism	is	also	a	potential	route	
of	viral	introduction.	Active	surveillance	of	domestic	swine	and	
efficient	channels	for	disease	reporting	are	imperative	to	allow	for	
the	rapid	diagnosis	of	infectious	disease	in	swine.
Classical	swine	fever	virus	introduction	in	feral	swine	would	
complicate	management	and	eradication.	Unrestricted	movement	
of	feral	swine	along	the	US,	Canada,	and	Mexico	borders	could	be	
an	issue	in	the	event	of	a	virus	introduction	into	any	of	the	three	
countries.	Simulation	models	have	demonstrated	that	CSFV-like	
pathogens	are	likely	to	persist	and	spread	across	the	landscape	in	
feral	swine	populations	(78,	86)	and	despite	active	antibody	sur-
veillance	it	is	likely	infeasible	to	sample	the	appropriate	number	of	
feral	pigs	in	order	to	reliably	determine	that	CSFV	is	not	present	
in	the	population	(84);	although	the	sampling	is	likely	sufficient	
for	a	morbidity	or	mortality	event.	However,	developing	detailed	
population	and	density	maps	for	the	feral	swine	population	in	the	
United	States	would	be	useful	 in	the	event	of	a	viral	 incursion.	
This	knowledge	could	be	harnessed	to	anticipate	risk	of	transmis-
sion	 to	domestic	 livestock	or	wildlife	 species	and	 to	determine	
strategies	 for	 preventing	 spread	 and	 eradicating	 the	 virus	 in	
the	 specific	 region	of	 concern.	 In	 conjunction	with	population	
density	mapping,	long-term	studies	on	a	fine	spatial	scale	should	
be	conducted	to	evaluate	contact	dynamics,	movement	ecology	
based	on	habitat,	and	seasonality	of	feral	swine.	Kramer-Schadt	
et al.	(94)	articulate	that	knowledge	of	social	structure,	dispersal,	
and	 population	 densities	 are	 key	 to	 understanding	 epidemics.	
Furthermore,	studies	evaluating	anthropogenic	causes	of	cluster-
ing	in	feral	swine	(e.g.	landfills,	bait	stations,	etc.)	would	be	very	
useful	 in	determining	 the	distance	of	 attraction	 for	 these	 food	
sources	and	how	their	presence	alters	both	the	natural	carrying	
capacity	for	feral	swine	as	well	as	their	behavior	and	any	related	
changes	in	home	range.	Finally,	further	analyses	should	be	per-
formed	to	determine	the	sampling	protocols	necessary	to	detect	
low	levels	of	CSF	antibody	prevalence	in	feral	swine.
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